BioDot Funding: How Much Did They Raise & Key Investors

How Much Did BioDot Raise?
Funding & Key Investors

BioDot, a manufacturer of automated ultralow volume fluid dispensing systems, has secured $350K in a major strategic investment, contributing to its total funding of $350K. This latest capital infusion underscores the company's established position in the market for advanced fluid handling solutions.

What is BioDot?

BioDot

Manufacturing

Test & Measurement Equipment

Industrial Machinery & Equipment

Founded in 1994 and based in Irvine, California, BioDot specializes in automated ultralow volume fluid dispensing systems. Its technology supports critical applications including the aspiration and dispensing of fluids, cell printing, and the development of lateral flow assays and microarray applications. The company's focus on precision fluid handling positions it as a key player in scientific instrumentation and diagnostics manufacturing.

How much funding has BioDot raised?

BioDot has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in BioDot

PPP

Public-Private Partnership

What's next for BioDot?

With the recent strategic investment and a substantial overall funding history of $350K, BioDot is poised for continued expansion and technological advancement. This significant backing suggests a focus on scaling operations, enhancing product development, and potentially broadening its market reach within the life sciences and diagnostics sectors. The company's trajectory indicates a strong emphasis on innovation in automated dispensing technologies.

See full BioDot company page

See More Financial Insights